The Top Analysis for Sonnet BioTherapeutics Holdings Inc (SONN)


The top analysis was written by Muhammad Shoaib titled Sonnet Biotherapeutics Holding Inc. | Sonn Stock Analysis

Is Sonnet BioTherapeutics Holdings Inc (SONN) a buy?

Based on 1 suggestion, Sonnet BioTherapeutics Holdings Inc(SONN) is recommended as a HOLD at $2.65.

Are These Ratings Good?

Based on 1 ratings, the average Return is -30.01%.
The community has not been successfully rating this stock.

Forecast for Sonnet BioTherapeutics Holdings Inc (SONN)

Based on the most recent price of $2.04,
the two year forecast for SONN is $2.14.
The four year forecast is $2.24
Forecast is based on the aggregate sentiment of users on the platform. The sentiment of top investors get a higher ranking when assessing the forecast.